$ARNA Recent News Arena shares surge as marketer doubles

New Post Public Reply Private Reply Replies (0) Message Board

Nov 8, 2013 at 4:41 PM

$ARNA Recent News

Arena shares surge as marketer doubles sales force for diet drug

11:41 a.m. Oct. 15, 2013

- Russ Britt

Obesity drug makers jockey for position as analysts praise Vivus

12:06 p.m. Oct. 3, 2013

- Russ Britt

Hedge funds are buying these stocks right now

1:46 p.m. July 23, 2013

- Insider Monkey

5 stocks insiders are buying

1:52 p.m. June 7, 2013

- Insider Monkey

6 gut checks before the stock market's opening bell

6:47 a.m. March 7, 2013

- Shawn Langlois

Stocks to watch Monday: Transocean, Stratasys

9:22 a.m. March 4, 2013

- Sue Chang

Arena Pharmaceuticals down 7.4% in premarket

9:11 a.m. Jan. 22, 2013

- Steve Gelsi

What 2012’s winners and losers say about 2013

6:00 a.m. Dec. 14, 2012

- Howard Gold

6 gut checks before the stock market's opening bell

6:50 a.m. Dec. 12, 2012

- Shawn Langlois

4 charts challenging resistance

7:06 a.m. Oct. 16, 2012

- The Trading Deck

Vivus sees EU regulators rejecting diet drug

12:16 p.m. Sept. 21, 2012

- MarketWatch.com

Vivus falls 11% on EU drug approval update

11:07 a.m. Sept. 21, 2012

- Val Brickates Kennedy

Arena rises as Vivus sees anti-obesity setback

7:49 a.m. Sept. 21, 2012

- Greg Morcroft

Vivus says Europe likely to reject obesity drug

7:33 a.m. Sept. 21, 2012

- MarketWatch.com

Orexigen soars 19% on analyst buy rating

12:46 p.m. Sept. 6, 2012

- Val Brickates Kennedy

Arena jumps 12% amid takeover speculation

1:55 p.m. Aug. 14, 2012

- Val Brickates Kennedy

Arena trips Nasdaq short-sale circuit breaker

3:01 p.m. Aug. 1, 2012

- Val Brickates Kennedy

Arena Pharma share drop trips short-sale limit

2:16 p.m. Aug. 1, 2012

- Laura Mandaro

Eisai gears up for launch of Arena's diet drug

9:32 a.m. July 30, 2012

- Val Brickates Kennedy

Apple, Arena active; Lumber Liquidators at new high

9:06 a.m. July 25, 2012

- blogs.marketwatch.com

VIVUS Loss In Line with Ests, Shares Fall - Analyst Blog

4:45 p.m. Nov. 7, 2013

- Zacks.com

Arena Pharmaceuticals, Eisai Expand Marketing and Supply Agreement for BELVIQ

3:03 p.m. Nov. 7, 2013

- benzinga.com

Arena's Belviq Refills - Week 20

12:43 a.m. Nov. 5, 2013

- Seeking Alpha

Arena Pharmaceuticals - Belviq OTC?

3:09 a.m. Nov. 4, 2013

- Seeking Alpha

Arena's Belviq - Week 20 Sales Data

1:28 p.m. Nov. 1, 2013

- Seeking Alpha

Arena Stock Reacts To Eisai Quarterly Call

10:26 a.m. Nov. 1, 2013

- Seeking Alpha

Should You Worry About the Short Interest in Arena Pharmaceuticals, Inc. (ARNA)? - Tale of the Tape

9:59 a.m. Nov. 1, 2013

- Zacks.com

Benzinga's Top #PreMarket Losers

7:13 a.m. Nov. 1, 2013

- benzinga.com

Uh Oh Arena Pharma! Q3 Belviq Sales Just $4.8M

7:09 a.m. Nov. 1, 2013

- TheStreet.com

A Look Back At Biotech Short Picks

2:18 p.m. Oct. 31, 2013

- Seeking Alpha

Interesting ARNA Put And Call Options For December 6th

10:46 a.m. Oct. 31, 2013

- TheStreet.com

Arena's Belviq Refills Week 19

3:29 a.m. Oct. 30, 2013

- Seeking Alpha

Latent Disconnect Between Arena's Fundamentals And Valuation

3:33 p.m. Oct. 29, 2013

- Seeking Alpha

Arena's Belviq Sales: Week 19

11:19 a.m. Oct. 25, 2013

- Seeking Alpha

November 29th Options Now Available For Arena Pharmaceuticals (ARNA)

11:15 a.m. Oct. 24, 2013

- TheStreet.com

Arena's Belviq Refills - Week 18 Data

4:26 p.m. Oct. 22, 2013

- Seeking Alpha

Arena's Belviq Sales Flat - Equity Holds

11:11 a.m. Oct. 18, 2013

- Seeking Alpha

Arena Pharmaceuticals, Inc. Enters Oversold Territory - Tale of the Tape

6:01 a.m. Oct. 18, 2013

- Zacks.com

Arena to Double Belviq Sales Force - Analyst Blog

12:50 p.m. Oct. 16, 2013

- Zacks.com

Arena Confirms Larger Sales Force For Belviq

2:51 p.m. Oct. 15, 2013

- Seeking Alpha

Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results

4:10 p.m. Nov. 7, 2013

- PR Newswire

Arena Pharmaceuticals and Eisai Expand Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) to Include Most Countries Worldwide

4:02 p.m. Nov. 7, 2013

- PR Newswire

FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech

8:00 a.m. Nov. 7, 2013

- PR Newswire

Must Watch Stock News: Arena Pharmaceuticals, Hewlett-Packard Company, Resorts International, Alpha Natural Resources, Chevron Corporation

1:56 p.m. Nov. 4, 2013

- PR Newswire

Pre-Market Review: Arena Pharma Inc., Geron Corp., Incyte Corp. Ltd, and Spectrum Pharma Inc.

9:00 a.m. Oct. 31, 2013

- PR Newswire

Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, November 7

8:00 a.m. Oct. 30, 2013

- PR Newswire

Sales Strategies, Upcoming Financial Results Schedules, Clinical Study Updates, and FDA Agreements - Research Report on Arena, Seattle Genetics, Halozyme, Insmed, and Omeros

8:00 a.m. Oct. 21, 2013

- PR Newswire

Arena Pharmaceuticals Reports That Eisai Will Double BELVIQ® (lorcaserin HCl) CIV Sales Force by December

9:03 a.m. Oct. 15, 2013

- PR Newswire

Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp.

9:26 a.m. Oct. 8, 2013

- PR Newswire

Drug Approvals, Data Presentations, Conferences, Increased Funding, and Merger Agreements - Research Report on Theravance, Arena, Exelixis, Verenium, and Enanta

8:00 a.m. Sept. 25, 2013

- PR Newswire

Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference

8:00 a.m. Sept. 23, 2013

- PR Newswire

Arena Pharmaceuticals to Present Clinical Data for BELVIQ® (lorcaserin HCl) CIV at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD)

8:00 a.m. Sept. 18, 2013

- PR Newswire

Arena Pharmaceuticals Provides Update as Eisai's Launch of BELVIQ® (lorcaserin HCl) CIV Enters Consumer Phase

8:00 a.m. Sept. 16, 2013

- PR Newswire

Track Insider Trading in Facebook, Zynga, Arena Pharmaceuticals, Lululemon Athletica, Weatherford International, and Bank of America

8:55 a.m. Sept. 13, 2013

- PR Newswire

Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX

9:05 a.m. Sept. 11, 2013

- ACCESSWIRE

Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference

8:00 a.m. Sept. 6, 2013

- PR Newswire

Successful Clinical Trials, Data Presentations, Promising Studies, Fulfilled Agreements and Investors Conferences - Research Report on Arena, BioMarin, Clovis Oncology, MannKind, and Medivation

8:00 a.m. Sept. 3, 2013

- PR Newswire

Five Star Equities Issues New Research Reports on ARNA, COCO, CWST and GES

8:40 a.m. Aug. 30, 2013

- ACCESSWIRE

Arena Pharmaceuticals Completes Phase 1b Clinical Trial Evaluating APD811 for Pulmonary Arterial Hypertension

8:00 a.m. Aug. 28, 2013

- PR Newswire

Innovus Pharma Provides Corporate Update

6:30 a.m. Aug. 19, 2013

- GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Melissa Rivers Brings Her Wit Back to Emmys Carpet

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Intus Bio Secures $2.7M for Colorectal Cancer Test

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

NYSE Reflects on 9/11: Honoring Lives and Legacy

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...

2026 Buy-Side Index Reveals State Market Variance

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

DCM Services Teams with AKUVO to Boost Estate Recoveries

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Streamlined AI Video Analytics for Public Safety Unveiled

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Americas Cardroom's Poker Series Hits $7.2M Haul

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

QuickFi Nabs Top Finovate Award for Fourth Time

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

Fermi's Founder Pushes for Board Overhaul: What's Next?

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Modeling and Mental Health Join Forces for Wellness

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...